deltatrials
Completed PHASE3 NCT00126256

Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer

Randomized Trial of Treatment Strategy for Chemotherapy in Colorectal Cancer, FFCD 2000-05

Sponsor: Fondation Francaise de Cancerologie Digestive

Conditions Colorectal Cancer Metastasis
Interventions 5-fluorouracil irinotecan leucovorin oxaliplatin
Updated 5 times since 2017 Last updated: Aug 11, 2015 Started: Feb 28, 2002 Primary completion: Feb 28, 2006 Completion: Feb 28, 2006

A PHASE3 clinical study on Colorectal Cancer and Metastasis, this trial is completed. The trial is conducted by Fondation Francaise de Cancerologie Digestive and has accumulated 5 data snapshots since 2002. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Feb 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fondation Francaise de Cancerologie Digestive
  • Gustave Roussy, Cancer Campus, Grand Paris
  • Sanofi
Data source: Gustave Roussy, Cancer Campus, Grand Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Villejuif, France